{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:49:44Z","timestamp":1792162184753,"version":"4.4.0"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25\\u202FK02752"],"award-info":[{"award-number":["25\\u202FK02752"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jns.2026.126219","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:47:36Z","timestamp":1791906456000},"page":"126219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reply to: Incremental value of a three-cytokine signature beyond IL-1\u03b2 in moyamoya disease"],"prefix":"10.1016","volume":"491","author":[{"given":"Silsu","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Mineharu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Funaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Chihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Sasagasako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.126219_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.126153","article-title":"Plasma signatures of type 2 inflammation and vascular remodeling in moyamoya disease","volume":"490","author":"Park","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.126219_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.126220","article-title":"Incremental value of a three-cytokine signature beyond IL-1\u03b2 in moyamoya disease","author":"Liu","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.126219_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.126217","article-title":"From cytokine discrimination to penetrance prediction in moyamoya disease: comment on Park et al","author":"Jiang","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2026.126219_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.126221","article-title":"Comment on \u201cplasma signatures of type 2 inflammation and vascular remodeling in moyamoya disease\u201d","author":"Wen","year":"2026","journal-title":"J. Neurol. Sci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26005010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26005010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:24:59Z","timestamp":1792160699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26005010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":4,"alternative-id":["S0022510X26005010"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126219","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reply to: Incremental value of a three-cytokine signature beyond IL-1\u03b2 in moyamoya disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126219"}}